Hurley Capital LLC Makes New $1.84 Million Investment in Encompass Health Co. (NYSE:EHC)

Hurley Capital LLC purchased a new position in Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 20,226 shares of the company's stock, valued at approximately $1,844,000. Encompass Health makes up 1.5% of Hurley Capital LLC's investment portfolio, making the stock its 20th biggest position.

Other hedge funds also recently bought and sold shares of the company. Dynamic Technology Lab Private Ltd acquired a new position in shares of Encompass Health during the 4th quarter valued at about $2,026,000. ExodusPoint Capital Management LP bought a new position in shares of Encompass Health in the fourth quarter valued at approximately $6,268,000. Cinctive Capital Management LP boosted its holdings in shares of Encompass Health by 143.1% during the 4th quarter. Cinctive Capital Management LP now owns 93,312 shares of the company's stock worth $8,617,000 after buying an additional 54,931 shares during the period. Trexquant Investment LP acquired a new position in Encompass Health in the 4th quarter valued at $3,885,000. Finally, Geode Capital Management LLC raised its holdings in Encompass Health by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company's stock worth $155,176,000 after acquiring an additional 6,164 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.10% of the stock is owned by insiders.

Remove Ads

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. StockNews.com lowered Encompass Health from a "buy" rating to a "hold" rating in a research note on Thursday, April 3rd. Royal Bank of Canada restated an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Finally, KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $107.67.

Encompass Health Trading Down 0.2 %

NYSE:EHC traded down $0.19 during trading hours on Thursday, hitting $103.01. 521,910 shares of the stock were exchanged, compared to its average volume of 656,444. The company's 50 day moving average is $99.51 and its two-hundred day moving average is $97.93. The company has a market capitalization of $10.37 billion, a P/E ratio of 22.96, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a twelve month low of $78.53 and a twelve month high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, sell-side analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.